Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study.

von Büren J, Hansen I, Kött J, Schröder F, Veneroso J, Schneider SW, Abeck F

Open source

DOI
10.1177/20552076231205740
Published
2023 Jan-Dec
Container
Digital health
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20552076231205740,
  title = {Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study.},
  author = {von Büren J and Hansen I and Kött J and Schröder F and Veneroso J and Schneider SW and Abeck F},
  year = {2023},
  journal = {Digital health},
  doi = {10.1177/20552076231205740},
  url = {https://doi.org/10.1177/20552076231205740}
}

RIS

TY  - JOUR
TI  - Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study.
AU  - von Büren J
AU  - Hansen I
AU  - Kött J
AU  - Schröder F
AU  - Veneroso J
AU  - Schneider SW
AU  - Abeck F
PY  - 2023
JO  - Digital health
DO  - 10.1177/20552076231205740
UR  - https://doi.org/10.1177/20552076231205740
ER  - 

APA

J, V. B., I, H., J, K., F, S., J, V., SW, S., & F, A. (2023). Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study.. Digital health. https://doi.org/10.1177/20552076231205740

Source records